AnalystsMatthew KellerMatthew Keller's Stock Forecasts
AnalystsMatthew Keller
Sectors:
Industries:
Analyst Ranking
Bottom 9%
#4861 out of 5279 analysts
Average Return
-20.08%
Win Rate
14%2 out of 14
Risk vs Reward
Poor
Good
Matthew Keller Analyst Color
Get additional color on Matthew Keller's coverage of popular stocks
Matthew Keller's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Inflarx NvIFRX | 3 | Buy | $8.00 | +223.89% | Maintains | 12 days ago |
Phio Pharmaceuticals CorpPHIO | 2 | Buy | $14.00 | +1,184.40% | Reiterates | 3 months ago |
60 Degrees Pharmaceuticals IncSXTP | 2 | Buy | $24.00 | +1,510.74% | Maintains | 4 months ago |
Galectin Therapeutics IncGALT | 2 | Buy | $11.00 | +336.51% | Maintains | 5 months ago |
Acurx Pharmaceuticals IncACXP | 2 | Buy | $31.00 | +1,506.22% | Reiterates | 8 months ago |
Kyntra Bio IncKYNB | 2 | Buy | $43.00 | +519.60% | Reiterates | 8 months ago |
Gyre Therapeutics IncGYRE | 1 | Buy | $18.00 | +191.26% | Initiates Coverage On | 9 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.